Delivery Order SPE2DB22D3016-SPE2DB24FAZH3

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $13,748.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYTARY ER 36.25 MG-145 MG capsules, a prescription drug. The contract is a Firm Fixed Price Delivery Order that runs through December 11, 2024. The award indicates that no set-aside designation was used. In addition to this specific contract, AmerisourceBergen...
This federal contract award, with a ceiling value of $10,521.87, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of RYTARY ER 61.25 MG-245 MG CAP 100S, a pharmaceutical product. The award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
This federal contract award, valued at $7,330.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product, over a period ending on May 9, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
The federal contract award provides $4,153.53 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver RYTARY ER 48.75 MG-195 MG capsules to the Defense Logistics Agency (DLA). This is a Firm Fixed Price delivery order contract with a completion date of May 30, 2024. The contract is not designated as a set-aside award. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which...
This federal contract award, valued at $3,379.50, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of RYTARY ER 48.75 MG-195 MG capsules, a prescription medication, to the government. There was no set-aside designation for this full and open competition award. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract...
This federal contract award, valued at $9,554.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of RYTARY ER 23.75 MG-95 MG CAP 100S, a prescription medication. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a prescription medication. The award, valued at $4,864.48, is a Firm Fixed Price Delivery Order with a completion date of February 12, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RYTARY ER 36.25 MG-145 MG CAP 100S, a prescription medication. The contract has a ceiling value of $5,252.23 and an ultimate completion date of August 5, 2024. The contract is a delivery order under a Firm Fixed Price arrangement, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $11,748.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RYTARY ER 36.25 MG-145 MG capsules, a prescription medication. The award is a delivery order against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,975.98, is for the delivery of RYTARY ER 48.75 MG-195 MG capsules. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a wide range of pharmaceutical products and...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FAZH3
    Delivery Order

This federal contract award, valued at $13,588.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a prescription medication. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/23/24, 10:05 AM